Journal of Ethnopharmacology, 116 (2), 325-332
If you are uncomfortable with the current valuations of LLY and NVO (dont be, theyre fine), I would recommend looking into more downstream effects where tailwinds provided by these drugs may not be priced in to expectations by the market and/or consensus estimates yet
Our Take What you do in the 30 minutes after a hard session determines your next one
Rather than viewing this as personal failure, it reflects the biological reality that certain individuals benefit from extended or ongoing GLP-1 therapy as chronic disease managementsimilar to how some people need lifelong blood pressure or cholesterol medications
In most cases, bulk substances are now allowed unless the compounded drug is on the FDAs drug shortage list at the time of compounding, distribution and dispensing. The agency said, after evaluating the proposed clinical need for semaglutide, tirzepatide, and liraglutide to be added to the list, a review of the evidence did not support a medical need for most instances of the drugs being administered in bulk
